000			01949 a2200589 4500
005			20250517204758.0
264		0	_c20180522
008			201805s 0 0 eng d
022			_a1573-2568
024	7		_a10.1007/s10620-018-5005-8 _2doi
040			_aNLM _beng _cNLM
100	1		_aAbdel-Moneim, Adel
245	0	0	_aRetreatment Efficacy of Sofosbuvir/Ombitasvir/Paritaprevir/Ritonavir + Ribavirin for Hepatitis C Virus Genotype 4 Patients. _h[electronic resource]
260			_bDigestive diseases and sciences _cMay 2018
300			_a1341-1347 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAnilides _xtherapeutic use
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aCarbamates _xtherapeutic use
650	0	4	_aCyclopropanes
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGenotype
650	0	4	_aHepacivirus _xgenetics
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aLactams, Macrocyclic
650	0	4	_aMacrocyclic Compounds _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProline _xanalogs & derivatives
650	0	4	_aRetreatment
650	0	4	_aRibavirin _xtherapeutic use
650	0	4	_aRitonavir _xtherapeutic use
650	0	4	_aSofosbuvir _xtherapeutic use
650	0	4	_aSulfonamides
650	0	4	_aSustained Virologic Response
650	0	4	_aTreatment Outcome
650	0	4	_aValine
650	0	4	_aYoung Adult
700	1		_aAboud, Alaa
700	1		_aAbdel-Gabbar, Mohamed
700	1		_aZanaty, Mohamed
700	1		_aRamadan, Mohamed
773	0		_tDigestive diseases and sciences _gvol. 63 _gno. 5 _gp. 1341-1347
856	4	0	_uhttps://doi.org/10.1007/s10620-018-5005-8 _zAvailable from publisher's website
999			_c28186258 _d28186258